JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

ISSN: Active
eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Letter to the Editor
A comment on ‘The relationship between hepatocellular carcinoma and resolvin D1’ by Erdin et al.
Abstract
We read the article entitled “The Relationship between Hepatocellular Carcinoma and Resolvin D1” by Erdin et al. with great interest. First of all, we congratulate the authors and editorial board for this informative and interesting article. Overall, this study by Erdin et al. demonstrated that Resolvin D1 may be a useful biomarker for predicting the HCC as an alternative to AFP. Further studies are warranted on this topic.

Keywords : Letter to the editor, hepatocellular carcinoma, resolvin D1

Download Article


1. Erdin Z, G&uuml;l &Ouml;, Erg&uuml;l B, et al. The relationship between hepatocellular carcinoma and resolvin D1. <em>J Curr Hematol Oncol Res</em>. 2023;1(4):96-101.
2. Yang M, Song XQ, Han M, et al. The role of resolvin D1 in liver diseases. <em>Prostaglandins Other Lipid Mediat</em>. 2022;160:106634.
3. Li J, Deng X, Wang S, et al. Resolvin D1 attenuates CCl4 induced liver fibrosis by inhibiting autophagy-mediated HSC activation via AKT/mTOR pathway. <em>Front Pharmacol</em>. 2021;12:792414.
Article available in :
Volume 2, Issue 4, 2024
Page : 100
https://doi.org/10.51271/JCHOR-0050
Article Information
Received : 27 Eki 2024
Accepted : 11 Kas 2024
Published : 14 Kas 2024
Corresponding Author :

İbrahim Ethem Güven: Department of Gastroenterology, Yenimahalle Training and Research Hospital, Ankara, Turkiye

[email protected]
Citation : Güven İE. The relationship between hepatocellular carcinoma and resolvin D1. J Curr Hematol Oncol Res. 2024;2(4):100.

Read: 96
Cited: 0
Download : 64
_Footer